Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Categorynews

All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen

January 27, 2024 Off By GlobeNewswire

Please read the full announcement in PDF
Attachment

2024_01_All_Regulatory_Approvals_Obtained

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email a link to a friend (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)

Related

Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024
All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Fresenius Kabi, TQ Therapeutics Announce Cell Therapy Technology Agreement

January 14, 2026 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine
Go to mobile version